Pseudomyxoma peritonei other imaging findings: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
Nima Nasiri (talk | contribs) |
||
Line 5: | Line 5: | ||
There are no other imaging findings associated with pseudomyxoma peritonei. | There are no other imaging findings associated with pseudomyxoma peritonei. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
Other imaging studies such as PET-scan may be used, preoperative 18F-FDG PET may predict pathological grade and completeness of cytoreduction which are the two main prognostic factors in patients with PMP.<ref name="pmid19818580">{{cite journal |vauthors=Passot G, Glehen O, Pellet O, Isaac S, Tychyj C, Mohamed F, Giammarile F, Gilly FN, Cotte E |title=Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction |journal=Eur J Surg Oncol |volume=36 |issue=3 |pages=315–23 |date=March 2010 |pmid=19818580 |doi=10.1016/j.ejso.2009.09.001 |url=}}</ref> | |||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 18:18, 7 January 2019
Pseudomyxoma peritonei Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pseudomyxoma peritonei other imaging findings On the Web |
American Roentgen Ray Society Images of Pseudomyxoma peritonei other imaging findings |
Risk calculators and risk factors for Pseudomyxoma peritonei other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
There are no other imaging findings associated with pseudomyxoma peritonei.
Other Imaging Findings
Other imaging studies such as PET-scan may be used, preoperative 18F-FDG PET may predict pathological grade and completeness of cytoreduction which are the two main prognostic factors in patients with PMP.[1]
References
- ↑ Passot G, Glehen O, Pellet O, Isaac S, Tychyj C, Mohamed F, Giammarile F, Gilly FN, Cotte E (March 2010). "Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction". Eur J Surg Oncol. 36 (3): 315–23. doi:10.1016/j.ejso.2009.09.001. PMID 19818580.